Skip to main content

Endocrinological Disorders

  • Chapter
  • First Online:
Radiation Therapy of Benign Diseases

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

  • 153 Accesses

Abstract

Gynecomastia is the benign proliferation of glandular tissue affecting more than half of men to some degree throughout their lives (Niewoehner and Nuttal 1984). The etiology is multifactorial; however, it involves a decrease in systemic androgens, increase in estrogen, or an enhanced tissue estrogen sensitivity (Georgiadis et al. 1994). Hormonal imbalances may be secondary to systemic illnesses, hypogonadism, diet, lifestyle choices, or certain medications; in all circumstances, treatment begins with conservative approaches aimed at addressing the underlying pathology with lifestyle modifications, consultation with an endocrinologist, and assessment of current medications (Di Lorenzo et al. 2005). Patients with recalcitrant disease may offer a variety of invasive approaches; more localized cases are amenable to liposuction, while for true symptomatic gynecomastia, surgery is accepted as a standard of care (Fruhstorfer and Malata 2003). While severe cases may require full mastectomies with free nipple grafts, this option is often reserved for the highest grades given scar burden and risk of nipple loss (Johnson and Murad 2009). In patients who are not surgical candidates, or who are placed on DES or feminizing hormones, radiation therapy can play a role in prevention or treatment. With the changing landscape of hormonal therapy for prostate cancer, radiotherapy is now less commonly used in these indications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abraham P, Acharya S (2010) Current and emerging treatment options for Graves’ hyperthyroidism. Ther Clin Risk Manag 6:29–40

    Google Scholar 

  • Alfthan O, Holsti LR (1969) Prevention of gynecomastia by local roentgen irradiation in estrogen-treated prostatic carcinoma. Scand J Urol Nephrol 3(3):183–187

    Google Scholar 

  • Allahabadia A, Daykin J, Holder RL et al (2000) Age and gender predict the outcome of treatment for Graves’ hyperthyroidism. J Clin Endocrinol Metab 85(3):1038–1042

    Google Scholar 

  • Beling U, Einhorn J (1961) Incidence of hypothyroidism and recurrences following I131 treatment of hyperthyroidism. Acta Radiol 56(4):275–288

    Google Scholar 

  • Blahd WH, Hays MT (1972) Graves’ disease in the male: a review of 241 cases treated with an individually calculated dose of sodium iodide I 131. Arch Intern Med 129(1):33–40

    Google Scholar 

  • Brown JS, Rubenfeld S (1974) Irradiation in preventing gynecomastia induced by estrogens. Urology 3(1):51–53

    Google Scholar 

  • Burke G (1969) Hypothyroidism after treatment with sodium iodide I 131. JAMA 210(6):1051

    Google Scholar 

  • Cevallos JL, Hagen GA, Maloof F et al (1974) Low-dosage 131I therapy of thyrotoxicosis (diffuse goiters). N Engl J Med 290(3):141–143

    Google Scholar 

  • Chou JL, Easley JD, Feldmeier JJ, Rauth VA, Pomeroy TC (1988) Effective radiotherapy in palliating mammalgia associated with gynecomastia after DES therapy. Int J Radiat Oncol Biol Phys 15(3):749–751

    Google Scholar 

  • Cook S, Rodriguez-Antunez A (1973) Pre-estrogen irradiation of the breast to prevent gynecomastia. Am J Roentgenol Radium Ther Nucl Med 117(3):662–663

    Google Scholar 

  • Corvalan JG, Gill WM Jr, Egleston TA, Rodriguez-Antunez A (1969) Irradiation of the male breast to prevent hormone produced gynecomastia. Am J Roentgenol Radium Ther Nucl Med 106(4):839–840

    Google Scholar 

  • Di Lorenzo G, Autorino R, Perdona S, De Placido S (2005) Management of gynaecomastia in patients with prostate cancer: a systematic review. Lancet Oncol 6(12):972–979

    Google Scholar 

  • Donovan JK, Turtle JR (1966) The results of radioiodine therapy in thyrotoxicosis. Med J Aust 2(6):271–272

    Google Scholar 

  • Dunn JT, Chapman EM (1964) Rising incidence of hypothyroidism after radioactive-iodine therapy in thyrotoxicosis. N Engl J Med 271(20):1037–1042

    Google Scholar 

  • Edsmyr F, Einhorn J (1966) Complications in radioiodine treatment of hyperthyroidism. Acta Radiol Ther Phys Biol 4(1):49–54

    Google Scholar 

  • Fass D, Steinfeld A, Brown J, Tessler A (1986) Radiotherapeutic prophylaxis of estrogen-induced gynecomastia: a study of late sequela. Int J Radiat Oncol Biol Phys 12(3):407–408

    Google Scholar 

  • Feibush JS, Sherman AA (1968) Low incidence of hypothyroidism following radioiodine therapy. Bronx-Lebanon Hospital Center, New York

    Google Scholar 

  • Franco J, Coppler M, Kovaleski B (1970) Propranolol and 131I in the treatment of diffuse thyroid hyperplasia with hyperthyroidism. J Nucl Med 11(5):219–220

    Google Scholar 

  • Fruhstorfer BH, Malata CM (2003) A systematic approach to the surgical treatment of gynaecomastia. Br J Plast Surg 56(3):237–246

    Google Scholar 

  • Georgiadis E, Papandreou L, Evangelopoulou C et al (1994) Incidence of gynaecomastia in 954 young males and its relationship to somatometric parameters. Ann Hum Biol 21(6):579–587

    Google Scholar 

  • Goolden AW, Fraser TR (1969) Effect of pretreatment with carbimazole in patients with thyrotoxicosis subsequently treated with radioactive iodine. Br Med J 3(5668):443–444

    Google Scholar 

  • Gronich N, Lavi I, Rennert G et al (2020) Cancer risk after radioactive iodine treatment for hyperthyroidism: a cohort study. Thyroid 30(2):243–250

    Google Scholar 

  • Hagen GA, Ouellette RP, Chapman EM (1967) Comparison of high and low dosage levels of 131I in the treatment of thyrotoxicosis. N Engl J Med 277(11):559–562

    Google Scholar 

  • Hamburger JI, Paul S (1968) When and how to use higher 131I doses for hyperthyroidism. N Engl J Med 279(25):1361–1365

    Google Scholar 

  • Hayek A, Chapman EM, Crawford JD (1970) Long-term results of treatment of thyrotoxicosis in children and adolescents with radioactive iodine. N Engl J Med 283(18):949–953

    Google Scholar 

  • Hertz S, Roberts A, Salter WT (1942) Radioactive iodine as an indicator in thyroid physiology. IV. The metabolism of iodine in Graves’ disease. J Clin Invest 21(1):25–29

    Google Scholar 

  • Jackson GL (1971) Radioiodine therapy of thyrotoxicosis. Am J Roentgenol 112(4):726–731

    Google Scholar 

  • Johnson RE, Murad MH (2009) Gynecomastia: pathophysiology, evaluation, and management. Mayo Clin Proc 84(11):1010–1015

    Google Scholar 

  • Joll CA (1933) X rays and radium in Graves’s disease. Br Med J 1(3764):338

    Google Scholar 

  • Kaipainen WJ, Vuopala U, Salokannel J et al (1970) Low dose radioactive iodine in the treatment of hyperthyroidism. Ann Clin Res 2(2):122

    Google Scholar 

  • Kempster C (1933) X rays and radium in Graves’s disease. Br Med J 1(3764):338

    Google Scholar 

  • Larsson L-G, Sundbom C-M (1962) Roentgen irradiation of the male breast. Acta Radiol 58(4):253–256

    Google Scholar 

  • Leslie WD, Ward L, Salamon EA et al (2003) A randomized comparison of radioiodine doses in Graves’ hyperthyroidism. J Clin Endocrinol Metab 88(3):978–983

    Google Scholar 

  • Lewitus Z, Lubin E, Rechnic J et al (1971) Treatment of thyrotoxicosis with 125I and 131I. Semin Nucl Med 1(4):411–421

    Google Scholar 

  • McDougall JR, Greig WR (1972) Combined carbimazole-131I treatment for thyrotoxicosis. Scott Med J 17(2):57–61

    Google Scholar 

  • Metso S, Jaatinen P, Huhtala H et al (2004) Long-term follow-up study of radioiodine treatment of hyperthyroidism. Clin Endocrinol (Oxf) 61(5):641–648

    Google Scholar 

  • Mizokami T, Hamada K, Maruta T et al (2020) Long-term outcomes of radioiodine therapy for juvenile Graves disease with emphasis on subsequently detected thyroid nodules: a single institution experience from Japan. Endocr Pract 26(7):729–737

    Google Scholar 

  • Neal FE (1965) Results of radioactive iodine treatment in thyrotoxicosis. Nucl Med Suppl 2:303+

    Google Scholar 

  • Niewoehner CB, Nuttal FQ (1984) Gynecomastia in a hospitalized male population. Am J Med 77(4):633–638

    Google Scholar 

  • Nofal MM (1966) Treatment of hyperthyroidism with sodium iodide I 131. JAMA 197(8):605

    Google Scholar 

  • Ozen H, Akyol F, Toktas G et al (2010) Is prophylactic breast radiotherapy necessary in all patients with prostate cancer and gynecomastia and/or breast pain? J Urol 184(2):519–524

    Google Scholar 

  • Perdona S, Autorino R, De Placido S et al (2005) Efficacy of tamoxifen and radiotherapy for prevention and treatment of gynaecomastia and breast pain caused by bicalutamide in prostate cancer: a randomised controlled trial. Lancet Oncol 6(5):295–300

    Google Scholar 

  • Reinwein D, Miss H, Horster FA et al (1969) Late results of fractionated radioiodine therapy. Follow-up studies of hyperthyroidism after 2 to 11 years. Ger Med Mon 14(5):234–238

    Google Scholar 

  • Ron E, Doody MM, Becker DV, et al. Cancer mortality following treatment for adult hyperthyroidism. JAMA. 1998;280(4):347–355. https://doi.org/10.1001/jama.280.4.347

  • Ross DS, Burch HB, Cooper DS et al (2016) 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26(10):1343–1421

    Google Scholar 

  • Sachs BA, Siegel E, Kass S et al (1972) Radioiodine therapy of thyrotoxicosis the Montefiore experience. Am J Roentgenol 115(4):698–705

    Google Scholar 

  • Saenger EL, Thoma GE, Tompkins EA (1968) Incidence of leukemia following treatment of hyperthyroidism: preliminary report of the Cooperative Thyrotoxicosis Therapy follow-up study. JAMA 205(12):855–862

    Google Scholar 

  • Safa AM, Schumacher OP, Rodriguez-Antunez A (1975) Long-term follow-up results in children and adolescents treated with radioactive iodine (131I) for hyperthyroidism. N Engl J Med 292(4):167–171

    Google Scholar 

  • Säterborg NE, Einhorn J (1966) Fractionated 131I therapy in large toxic goitres. Acta Endocrinol 51(1):7–14

    Google Scholar 

  • Smith RN, Wilson GM (1967) Clinical trial of different doses of 131-I in treatment of thyrotoxicosis. Br Med J 1(5533):129

    Google Scholar 

  • Srinivasan V, Miree J Jr, Lloyd FA (1972) Bilateral mastectomy and irradiation in the prevention of estrogen induced gynecomastia. J Urol 107(4):624–625

    Google Scholar 

  • Tezcan UP, Frelick RW, Meckelnburg RL (1967) Low dose therapy of hyperthyroidism. Wilmington Medical Center, Wilmington, DE

    Google Scholar 

  • Thjodleifsson B (1975) A study of Graves’ disease in Iceland. Acta Med Scand 198(1–6):309–314

    Google Scholar 

  • Tunbridge WM, Harsoulis P, Goolden AW (1974) Thyroid function in patients treated with radioactive iodine for thyrotoxicosis. Br Med J 3(5923):89–92

    Google Scholar 

  • Tyrrell CJ, Payne H, Tammela TL et al (2004) Prophylactic breast irradiation with a single dose of electron beam radiotherapy (10 Gy) significantly reduces the incidence of bicalutamide-induced gynecomastia. Int J Radiat Oncol Biol Phys 60(2):476–483

    Google Scholar 

  • Van Poppel H, Tyrrell CJ, Haustermans K et al (2005) Efficacy and tolerability of radiotherapy as treatment for bicalutamide-induced gynaecomastia and breast pain in prostate cancer. Eur Urol 47(5):587–592

    Google Scholar 

  • Viherkoski M, Lamberg BA, Hernberg CA et al (1970) Treatment of toxic nodular and diffuse goitre with radioactive iodine. Acta Endocrinol 64(1):159–170

    Google Scholar 

  • Wang J, Qin L (2016) Radioiodine therapy versus antithyroid drugs in Graves’ disease: a meta-analysis of randomized controlled trials. Br J Radiol 89(1064):20160418

    Google Scholar 

  • Waterfall NB, Glaser MG (1979) A study of the effects of radiation on prevention of gynaecomastia due to oestrogen therapy. J Clin Oncol 5(3):257–260

    Google Scholar 

  • Widmark A, Fossa SD, Lundmo P et al (2003) Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3. Urology 61(1):145–151

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tyler Safran .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Safran, T., Juneau, D. (2023). Endocrinological Disorders. In: Roberge, D., Donaldson, S.S. (eds) Radiation Therapy of Benign Diseases. Medical Radiology(). Springer, Cham. https://doi.org/10.1007/174_2022_372

Download citation

  • DOI: https://doi.org/10.1007/174_2022_372

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-35516-5

  • Online ISBN: 978-3-031-35517-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics